Cynomolgus HGF R/c-MET Protein (MET-CM101)
KACTUS Biosystems Cynomolgus HGF R/c-MET Protein (MET-CM101) (catalog No. MET-CM101) is expressed from HEK293 with His tag at the C-Terminus.It contains Glu25-Asn930.
KACTUS Biosystems Cynomolgus HGF R/c-MET Protein (MET-CM101) (catalog No. MET-CM101) is expressed from HEK293 with His tag at the C-Terminus.It contains Glu25-Asn930.
KACTUS Biosystems Human HGF R/c-MET Protein (MET-HM201) (catalog No. MET-HM201) is expressed from HEK293 with hFc tag at the C-Terminus.It contains Glu25-Thr932.
KACTUS Biosystems Human HGF R/c-MET Protein (MET-HM401) (catalog No. MET-HM401) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Glu25-Thr932.
KACTUS Biosystems Biotinylated Human HGF R/c-MET Protein (MET-HM401B) (catalog No. MET-HM401B) is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Glu25-Thr932.
Recombinant mouse anti-mouse GITR / CD357 monoclonal antibody (Clone DTA-1, Biotinylated), engineered with a Human IgG1 Fc-Silent domain to minimize non-specific Fc receptor binding during flow cytometry and T cell activation research. Variable regions are...
Recombinant mouse anti-mouse PD-1 / CD279 monoclonal antibody (Clone RMP1-14.1, Biotinylated), engineered with a Human IgG1 Fc-Silent domain to minimize non-specific Fc receptor binding during flow cytometry and immune checkpoint analysis. Variable regions are derived...
Recombinant anti-mouse GITR monoclonal antibodies from the variable region sequences of the rat anti-mouse GITR monoclonal antibody (clone number: DTA-1) are produced from mammalian cells and good for in vitro and in vivo studies.
Recombinant anti-mouse GITR monoclonal antibodies from the variable region sequences of the rat anti-mouse GITR monoclonal antibody (clone number: DTA-1) are produced from mammalian cells and good for in vitro and in vivo studies.
Recombinant rat IgG2a isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2a isotype controls and Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.